Tag : IDs

Gastroenterology

Study IDs 'Standard' Chemo for BRCA, PALB2 Pancreatic Cancer

Newsemia
<![CDATA[]]>(MedPage Today) — SAN FRANCISCO — Gemcitabine (Gemzar) plus cisplatin should be considered a standard for metastatic pancreatic cancer patients with germline BRCA or PALB2...
Cardiology

The OPTIMIZE randomized trial to assess safety and efficacy of the Svelte IDS and RX Sirolimus-eluting coronary stent Systems for the Treatment of atherosclerotic lesions: Trial design and rationale.

Newsemia
Related Articles The OPTIMIZE randomized trial to assess safety and efficacy of the Svelte IDS and RX Sirolimus-eluting coronary stent Systems for the Treatment of...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy